RESUMO
Diffusion weighted imaging (DWI) is key in clinical neuroimaging studies. In recent years, DWI has undergone rapid evolution and increasing applications. Diffusion magnetic resonance imaging (dMRI) is widely used to analyse group-level differences in white matter (WM), but suffers from limitations that can be particularly impactful in clinical groups where 1) structural abnormalities may increase erroneous inter-subject registration and 2) subtle differences in WM microstructure between individuals can be missed. It also lacks standardization protocols for analyses at the subject level. Region of Interest (ROI) analyses in native diffusion space can help overcome these challenges, with manual segmentation still used as the gold standard. However, robust automated approaches for the analysis of ROI-extracted native diffusion characteristics are limited. Subject-Specific Diffusion Segmentation (SSDS) is an automated pipeline that uses pre-existing imaging analysis methods to carry out WM investigations in native diffusion space, while overcoming the need to interpolate diffusion images and using an intermediate T1 image to limit registration errors and guide segmentation. SSDS is validated in a cohort of healthy subjects scanned three times to derive test-retest reliability measures and compared to other methods, namely manual segmentation and tract-based spatial statistics as an example of group-level method. The performance of the pipeline is further tested in a clinical population of patients with traumatic brain injury and structural abnormalities. Mean FA values obtained from SSDS showed high test-retest and were similar to FA values estimated from the manual segmentation of the same ROIs (p-value > 0.1). The average dice similarity coefficients (DSCs) comparing results from SSDS and manual segmentations was 0.8 ± 0.1. Case studies of TBI patients showed robustness to the presence of significant structural abnormalities, indicating its potential clinical application in the identification and diagnosis of WM abnormalities. Further recommendation is given regarding the tracts used with SSDS.
Assuntos
Imagem de Difusão por Ressonância Magnética , Humanos , Reprodutibilidade dos TestesRESUMO
Prader-Willi syndrome (PWS) is the most common genetic obesity syndrome, with associated learning difficulties, neuroendocrine deficits, and behavioural and psychiatric problems. As the life expectancy of individuals with PWS increases, there is concern that alterations in brain structure associated with the syndrome, as a direct result of absent expression of PWS genes, and its metabolic complications and hormonal deficits, might cause early onset of physiological and brain aging. In this study, a machine learning approach was used to predict brain age based on grey matter (GM) and white matter (WM) maps derived from structural neuroimaging data using T1-weighted magnetic resonance imaging (MRI) scans. Brain-predicted age difference (brain-PAD) scores, calculated as the difference between chronological age and brain-predicted age, are designed to reflect deviations from healthy brain aging, with higher brain-PAD scores indicating premature aging. Two separate adult cohorts underwent brain-predicted age calculation. The main cohort consisted of adults with PWS (nâ¯=â¯20; age mean 23.1â¯years, range 19.8-27.7; 70.0% male; body mass index (BMI) mean 30.1â¯kg/m2, 21.5-47.7; nâ¯=â¯19 paternal chromosome 15q11-13 deletion) and age- and sex-matched controls (nâ¯=â¯40; age 22.9â¯years, 19.6-29.0; 65.0% male; BMI 24.1â¯kg/m2, 19.2-34.2) adults (BMI PWS vs. control Pâ¯=â¯.002). Brain-PAD was significantly greater in PWS than controls (effect size mean⯱â¯SEM +7.24⯱â¯2.20â¯years [95% CI 2.83, 11.63], Pâ¯=â¯.002). Brain-PAD remained significantly greater in PWS than controls when restricting analysis to a sub-cohort matched for BMI consisting of nâ¯=â¯15 with PWS with BMI range 21.5-33.7â¯kg/m2, and nâ¯=â¯29 controls with BMI 21.7-34.2â¯kg/m2 (effect size +5.51⯱â¯2.56â¯years [95% CI 3.44, 10.38], Pâ¯=â¯.037). In the PWS group, brain-PAD scores were not associated with intelligence quotient (IQ), use of hormonal and psychotropic medications, nor severity of repetitive or disruptive behaviours. A 24.5â¯year old man (BMI 36.9â¯kg/m2) with PWS from a SNORD116 microdeletion also had increased brain PAD of 12.87â¯years, compared to 0.84⯱â¯6.52â¯years in a second control adult cohort (nâ¯=â¯95; age mean 34.0â¯years, range 19.9-55.5; 38.9% male; BMI 28.7â¯kg/m2, 19.1-43.1). This increase in brain-PAD in adults with PWS indicates abnormal brain structure that may reflect premature brain aging or abnormal brain development. The similar finding in a rare patient with a SNORD116 microdeletion implicates a potential causative role for this PWS region gene cluster in the structural brain abnormalities associated primarily with the syndrome and/or its complications. Further longitudinal neuroimaging studies are needed to clarify the natural history of this increase in brain age in PWS, its relationship with obesity, and whether similar findings are seen in those with PWS from maternal uniparental disomy.